Filgrastim-SD/01

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI), Schwartzberg, Lee, M.D.

Conditions

Ewing's SarcomaHigh-risk SarcomaMPNSTNon-small Cell Lung CancerRhabdomyosarcomaSynovial Sarcoma

Phase 1

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

CompletedNCT00004853

National Cancer Institute (NCI)Ewing's Sarcoma, High-risk Sarcoma, MPNST +2

Start: 2000-03-03End: 2009-05-20Updated: 2019-11-12

Phase 2

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

CompletedNCT00050674

Schwartzberg, Lee, M.D.Non-small Cell Lung Cancer

Start: 2001-11-30End: 2007-02-28Updated: 2012-12-27